Evidence map›Paper›PMID 40034914›Full record

ArticleIJU case reports2025

Renal metastasis of hepatocellular carcinoma after living donor liver transplantation.

Yo Nakamura, Jun Kamei, Ryo Tanaka, Yoichi Yasunaga, Nobuhisa Akamatsu, Satoru Taguchi, Shigenori Kakutani, Yuta Yamada, Aya Niimi, Daisuke Yamada and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IJU case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yo NakamuraDepartment of Urology Graduate School of Medicine, The University of Tokyo Tokyo Japan.
Jun KameiDepartment of Urology Graduate School of Medicine, The University of Tokyo Tokyo Japan.ORCID https://orcid.org/0000-0002-0069-7392
Ryo TanakaDepartment of Urology Graduate School of Medicine, The University of Tokyo Tokyo Japan.
Yoichi YasunagaDepartment of Pathology Graduate School of Medicine, The University of Tokyo Tokyo Japan.
Nobuhisa AkamatsuHepato-Biliary-Pancreatic Surgery Division, Artificial Organ and Transplantation Division, Department of Surgery, The University of Tokyo Tokyo Japan.
Satoru TaguchiDepartment of Urology Graduate School of Medicine, The University of Tokyo Tokyo Japan.ORCID https://orcid.org/0000-0002-1291-4294
Shigenori KakutaniDepartment of Urology Graduate School of Medicine, The University of Tokyo Tokyo Japan.
Yuta YamadaDepartment of Urology Graduate School of Medicine, The University of Tokyo Tokyo Japan.
Aya NiimiDepartment of Urology Graduate School of Medicine, The University of Tokyo Tokyo Japan.
Daisuke YamadaDepartment of Urology Graduate School of Medicine, The University of Tokyo Tokyo Japan.
Haruki KumeDepartment of Urology Graduate School of Medicine, The University of Tokyo Tokyo Japan.ORCID https://orcid.org/0000-0001-9841-0857

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: We report a case of renal metastasis of hepatocellular carcinoma in a liver transplant recipient. Case presentation: A 66-year-old man who was diagnosed with hepatocellular carcinoma and considered to be in complete remission for 7 years underwent living donor liver transplantation. A residual tumor was found in the removed native liver. Computed tomography at 13 months after transplantation revealed a 24-mm hypervascular tumor with arterial phase enhancement, venous phase washout in the right kidney, and increasing hepatocellular carcinoma tumor markers. Partial nephrectomy was performed and the renal tumor was diagnosed as renal metastasis of hepatocellular carcinoma. Tumor marker levels decreased temporarily, but pulmonary metastasis and pleural dissemination subsequently appeared. Conclusion: Renal metastasis of hepatocellular carcinoma should be considered when renal tumors are detected in liver transplant recipients because the risks of tumor recurrence and metastasis are increased.

Indexed as

hepatocellular carcinomakidney neoplasmsliver transplantationpartial nephrectomyrenal metastasis

Identifiers

PMID40034914
PMCPMC11872214

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.